The Indian pharmaceutical industry aims for a strategic transition from its traditional role as a volume-driven generics ...
Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy ...
Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...
Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...
A team of scientists at The University of Texas Medical Branch (UTMB), led by Nikos Vasilakis, Ph.D., and Peter McCaffrey, MD ...
Neuland Laboratories appoints Saharsh Davuluri as CEO to lead its $30m peptide facility expansion, targeting growth in ...
In 2026, AI will gain traction in life sciences and biopharmaceuticals, but the key to success is AI that goes deep into the ...
To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...
The global unit will be headed by Armin Metzger, who will join Sandoz on April 1, 2026. Metzger, who will be president of biosimilar development, manufacturing and supply, joins Sandoz from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results